BiotechTube

BL-1020 + BL 1020 High Dose

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Schizophrenia

Conditions

Schizophrenia, Schizoaffective Disorder

Trial Timeline

Jun 1, 2007 → Dec 1, 2007

NCT ID
NCT00480571

About BL-1020 + BL 1020 High Dose

BL-1020 + BL 1020 High Dose is a phase 2 stage product being developed by BioLineRx for Schizophrenia. The current trial status is completed. This product is registered under clinical trial identifier NCT00480571. Target conditions include Schizophrenia, Schizoaffective Disorder.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT00480571Phase 2Completed

Competing Products

20 competing products in Schizophrenia

See all competitors
ProductCompanyStageHype Score
antipsychotic dose increaseEli LillyPre-clinical
23
Olanzapine + PlaceboEli LillyPhase 3
77
Olanzapine + AripiprazoleEli LillyApproved
85
olanzapine therapyEli LillyApproved
85
olanzapine-RAIM + placeboEli LillyPhase 2
52
Clozapine + OlanzapineEli LillyApproved
85
AtomoxetineEli LillyApproved
85
Risperidone + Placebo + LY2140023Eli LillyPhase 2
52
Olanzapine + olanzapine + risperidoneEli LillyApproved
85
Zotepine + RisperidoneAstellas PharmaApproved
85
ASP4345 + Matching PlaceboAstellas PharmaPhase 1
33
ASP4345 + placebo + risperidone + quetiapine + olanzapine + ziprasidone + aripiprazole + brexpiprazole + paliperidone + lurasidoneAstellas PharmaPhase 2
52
ASP6981 + PlaceboAstellas PharmaPhase 1
33
SAPHRIS + AsenapineSun PharmaceuticalPhase 1
33
Torrent's Quetiapine Fumarate TabletsTorrent PharmaceuticalsPhase 1
33
Olanzapine HydrochlorideEli LillyPhase 1/2
41
Rapid-Acting Intramuscular Olanzapine + PlaceboEli LillyPhase 3
77
Pomaglumetad methionilEli LillyPhase 3
77
OlanzapineEli LillyApproved
85
Intramuscular Olanzapine Depot + PlaceboEli LillyPhase 3
77

Other Products from BioLineRx

BL-8040 1.25 mg/kg + G-CSF + Placebo +G-CSFPhase 3
69
CYP-1020 + RisperidonePhase 2/3
57
BL-8040Phase 2
44
BL - 1020 + BL - 1020 + Placebo + RisperidonePhase 2
44
BL-8040 + horse anti-thymocyte globulin (hATG) + Methylprednisolone + CyclosporinePhase 2
44